{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:40:39Z","timestamp":1740123639217,"version":"3.37.3"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,8,5]],"date-time":"2016-08-05T00:00:00Z","timestamp":1470355200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Helse Nord","award":["SFP1161-14"],"award-info":[{"award-number":["SFP1161-14"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s10689-016-9916-2","type":"journal-article","created":{"date-parts":[[2016,8,5]],"date-time":"2016-08-05T13:17:07Z","timestamp":1470403027000},"page":"1-16","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Characterization of BRCA1 and BRCA2 variants found in a Norwegian breast or ovarian cancer cohort"],"prefix":"10.1007","volume":"16","author":[{"given":"Elisabeth","family":"Jarhelle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilde Monica Frostad","family":"Riise Stensland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lovise","family":"M\u00e6hle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8687-6374","authenticated-orcid":false,"given":"Marijke","family":"Van Ghelue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,5]]},"reference":[{"key":"9916_CR1","doi-asserted-by":"publisher","unstructured":"Safran M, Dalah I, Alexander J, et al (2010) GeneCards Version 3: the human gene integrator. Database (Oxford) 2010: baq020 DOI 10.1093\/database\/baq020","DOI":"10.1093\/database\/baq020"},{"issue":"1","key":"9916_CR2","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nrc3181","volume":"12","author":"R Roy","year":"2012","unstructured":"Roy R, Chun J, Powell SN (2012) BRCA1 and BRCA2: different roles in a common pathway of genome protection. Nat Rev Cancer 12(1):68\u201378. doi: 10.1038\/nrc3181","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"9916_CR3","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1038\/embor.2009.126","volume":"10","author":"AW Oliver","year":"2009","unstructured":"Oliver AW, Swift S, Lord CJ, Ashworth A, Pearl LH (2009) Structural basis for recruitment of BRCA2 by PALB2. EMBO Rep 10(9):990\u2013996. doi: 10.1038\/embor.2009.126","journal-title":"EMBO Rep"},{"issue":"7","key":"9916_CR4","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1136\/jmedgenet-2015-103672","volume":"53","author":"K Kast","year":"2016","unstructured":"Kast K, Rhiem K, Wappenschmidt B et al (2016) Prevalence of BRCA1\/2 germline mutations in 21 401 families with breast and ovarian cancer. J Med Genet 53(7):465\u2013471. doi: 10.1136\/jmedgenet-2015-103672","journal-title":"J Med Genet"},{"issue":"6","key":"9916_CR5","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1200\/JCO.20.6.1480","volume":"20","author":"TS Frank","year":"2002","unstructured":"Frank TS, Deffenbaugh AM, Reid JE, et al (2002) Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 20(6):1480\u20131490","journal-title":"J Clin Oncol"},{"issue":"4","key":"9916_CR6","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1365-2796.2011.02502.x","volume":"271","author":"DR Barnes","year":"2012","unstructured":"Barnes DR, Antoniou AC (2012) Unravelling modifiers of breast and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: update on genetic modifiers. J Intern Med 271(4):331\u2013343. doi: 10.1111\/j.1365-2796.2011.02502.x","journal-title":"J Intern Med"},{"issue":"6","key":"9916_CR7","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1136\/jmg.2009.074047","volume":"47","author":"P Gaildrat","year":"2010","unstructured":"Gaildrat P, Krieger S, Thery JC et al (2010) The BRCA1 c.5434C\u00a0\u2192\u00a0G (p. Pro1812Ala) variant induces a deleterious exon 23 skipping by affecting exonic splicing regulatory elements. J Med Genet 47(6):398\u2013403. doi: 10.1136\/jmg.2009.074047","journal-title":"J Med Genet"},{"issue":"4","key":"9916_CR8","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/ng1294-399","volume":"8","author":"LS Friedman","year":"1994","unstructured":"Friedman LS, Ostermeyer EA, Szabo CI et al (1994) Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat Genet 8(4):399\u2013404. doi: 10.1038\/ng1294-399","journal-title":"Nat Genet"},{"issue":"2","key":"9916_CR9","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/(SICI)1096-8628(19981102)80:2<140::AID-AJMG10>3.0.CO;2-L","volume":"80","author":"JD Hoffman","year":"1998","unstructured":"Hoffman JD, Hallam SE, Venne VL, Lyon E, Ward K (1998) Implications of a novel cryptic splice site in the BRCA1 gene. Am J Med Genet 80(2):140\u2013144","journal-title":"Am J Med Genet"},{"issue":"1","key":"9916_CR10","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0165-4608(98)00009-0","volume":"105","author":"S Fetzer","year":"1998","unstructured":"Fetzer S, Tworek HA, Piver MS, Dicioccio RA (1998) An alternative splice site junction in exon 1a of the BRCA1 gene. Cancer Genet Cytogenet 105(1):90\u201392","journal-title":"Cancer Genet Cytogenet"},{"issue":"14","key":"9916_CR11","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1093\/hmg\/ddu075","volume":"23","author":"M Colombo","year":"2014","unstructured":"Colombo M, Blok MJ, Whiley P et al (2014) Comprehensive annotation of splice junctions supports pervasive alternative splicing at the BRCA1 locus: a report from the ENIGMA consortium. Hum Mol Genet 23(14):3666\u20133680. doi: 10.1093\/hmg\/ddu075","journal-title":"Hum Mol Genet"},{"issue":"2","key":"9916_CR12","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/humu.1164","volume":"18","author":"A Jakubowska","year":"2001","unstructured":"Jakubowska A, Gorski B, Byrski T et al (2001) Detection of germline mutations in the BRCA1 gene by RNA-based sequencing. Hum Mutat 18(2):149\u2013156. doi: 10.1002\/humu.1164","journal-title":"Hum Mutat"},{"key":"9916_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2015-103570","author":"JD Fackenthal","year":"2016","unstructured":"Fackenthal JD, Yoshimatsu T, Zhang B et al (2016) Naturally occurring BRCA2 alternative mRNA splicing events in clinically relevant samples. J Med Genet. doi: 10.1136\/jmedgenet-2015-103570","journal-title":"J Med Genet"},{"issue":"9","key":"9916_CR14","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/nrc1431","volume":"4","author":"SA Narod","year":"2004","unstructured":"Narod SA, Foulkes WD (2004) BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer 4(9):665\u2013676. doi: 10.1038\/nrc1431","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"9916_CR15","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1158\/0008-5472.CAN-06-3297","volume":"67","author":"MA Carvalho","year":"2007","unstructured":"Carvalho MA, Marsillac SM, Karchin R et al (2007) Determination of cancer risk associated with germ line BRCA1 missense variants by functional analysis. Cancer Res 67(4):1494\u20131501. doi: 10.1158\/0008-5472.CAN-06-3297","journal-title":"Cancer Res"},{"issue":"1","key":"9916_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/(SICI)1098-1004(200001)15:1<7::AID-HUMU4>3.0.CO;2-N","volume":"15","author":"JT Dunnen den","year":"2000","unstructured":"den Dunnen JT, Antonarakis SE (2000) Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 15(1):7\u201312. doi: 10.1002\/(SICI)1098-1004(200001)15:1<7:AID-HUMU4>3.0.CO;2-N","journal-title":"Hum Mutat"},{"issue":"15","key":"9916_CR17","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1093\/nar\/gks596","volume":"40","author":"A Untergasser","year":"2012","unstructured":"Untergasser A, Cutcutache I, Koressaar T et al (2012) Primer3\u2014new capabilities and interfaces. Nucl Acids Res 40(15):e115. doi: 10.1093\/nar\/gks596","journal-title":"Nucl Acids Res"},{"issue":"10","key":"9916_CR18","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/bioinformatics\/btm091","volume":"23","author":"T Koressaar","year":"2007","unstructured":"Koressaar T, Remm M (2007) Enhancements and modifications of primer design program Primer3. Bioinformatics 23(10):1289\u20131291. doi: 10.1093\/bioinformatics\/btm091","journal-title":"Bioinformatics"},{"key":"9916_CR19","unstructured":"Sequencher\u00ae version 5.3 sequence analysis software. Gene Codes Corporation, Ann Arbor, MI USA. http:\/\/www.genecodes.com"},{"issue":"1","key":"9916_CR20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/humu.21627","volume":"33","author":"NM Lindor","year":"2012","unstructured":"Lindor NM, Guidugli L, Wang X et al (2012) A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS). Hum Mutat 33(1):8\u201321. doi: 10.1002\/humu.21627","journal-title":"Hum Mutat"},{"issue":"6","key":"9916_CR21","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3233\/DMA-2012-0893","volume":"32","author":"F Cherbal","year":"2012","unstructured":"Cherbal F, Salhi N, Bakour R, Adane S, Boualga K, Maillet P (2012) BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast\/ovarian cancer families. Dis Markers 32(6):343\u2013353. doi: 10.3233\/DMA-2012-0893","journal-title":"Dis Markers"},{"issue":"8","key":"9916_CR22","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1136\/jmedgenet-2012-101037","volume":"49","author":"AB Spurdle","year":"2012","unstructured":"Spurdle AB, Whiley PJ, Thompson B et al (2012) BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk. J Med Genet 49(8):525\u2013532. doi: 10.1136\/jmedgenet-2012-101037","journal-title":"J Med Genet"},{"issue":"10","key":"9916_CR23","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1158\/2159-8290.CD-13-0094","volume":"3","author":"P Bouwman","year":"2013","unstructured":"Bouwman P, van der Gulden H, van der Heijden I et al (2013) A high-throughput functional complementation assay for classification of BRCA1 missense variants. Cancer Discov 3(10):1142\u20131155. doi: 10.1158\/2159-8290.CD-13-0094","journal-title":"Cancer Discov"},{"issue":"6","key":"9916_CR24","doi-asserted-by":"publisher","first-page":"R82","DOI":"10.1186\/bcr1826","volume":"9","author":"PK Lovelock","year":"2007","unstructured":"Lovelock PK, Spurdle AB, Mok MT et al (2007) Identification of BRCA1 missense substitutions that confer partial functional activity: Potential moderate risk variants? Breast Cancer Res 9(6):R82. doi: 10.1186\/bcr1826","journal-title":"Breast Cancer Res"},{"issue":"1","key":"9916_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2012.07.083","volume":"514","author":"O Kelemen","year":"2013","unstructured":"Kelemen O, Convertini P, Zhang Z et al (2013) Function of alternative splicing. Gene 514(1):1\u201330. doi: 10.1016\/j.gene.2012.07.083","journal-title":"Gene"},{"issue":"5","key":"9916_CR26","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1086\/521032","volume":"81","author":"DF Easton","year":"2007","unstructured":"Easton DF, Deffenbaugh AM, Pruss D et al (2007) A systematic genetic assessment of 1433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes. Am J Hum Genet 81(5):873\u2013883. doi: 10.1086\/521032","journal-title":"Am J Hum Genet"},{"issue":"2","key":"9916_CR27","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1086\/514856","volume":"61","author":"TA Cooper","year":"1997","unstructured":"Cooper TA, Mattox W (1997) The regulation of splice-site selection, and its role in human disease. Am J Hum Genet 61(2):259\u2013266. doi: 10.1086\/514856","journal-title":"Am J Hum Genet"},{"key":"9916_CR28","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddw094","author":"M Hoya","year":"2016","unstructured":"Hoya M, Soukarieh O, Lopez-Perolio I et al (2016) Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms. Hum Mol Genet. doi: 10.1093\/hmg\/ddw094","journal-title":"Hum Mol Genet"},{"issue":"1","key":"9916_CR29","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/bfgp\/els051","volume":"12","author":"IM Palacios","year":"2013","unstructured":"Palacios IM (2013) Nonsense-mediated mRNA decay: from mechanistic insights to impacts on human health. Brief Funct Genom 12(1):25\u201336. doi: 10.1093\/bfgp\/els051","journal-title":"Brief Funct Genom"},{"issue":"10","key":"9916_CR30","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1002\/humu.20384","volume":"27","author":"M Buisson","year":"2006","unstructured":"Buisson M, Anczukow O, Zetoune AB, Ware MD, Mazoyer S (2006) The 185delAG mutation (c.68_69delAG) in the BRCA1 gene triggers translation reinitiation at a downstream AUG codon. Hum Mutat 27(10):1024\u20131029. doi: 10.1002\/humu.20384","journal-title":"Hum Mutat"},{"issue":"6055","key":"9916_CR31","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1126\/science.1209909","volume":"334","author":"R Shakya","year":"2011","unstructured":"Shakya R, Reid LJ, Reczek CR et al (2011) BRCA1 tumor suppression depends on BRCT phosphoprotein binding, but not its E3 ligase activity. Science 334(6055):525\u2013528. doi: 10.1126\/science.1209909","journal-title":"Science"},{"issue":"1","key":"9916_CR32","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/humu.20811","volume":"30","author":"MP Vreeswijk","year":"2009","unstructured":"Vreeswijk MP, Kraan JN, van der Klift HM et al (2009) Intronic variants in BRCA1 and BRCA2 that affect RNA splicing can be reliably selected by splice-site prediction programs. Hum Mutat 30(1):107\u2013114. doi: 10.1002\/humu.20811","journal-title":"Hum Mutat"},{"issue":"6","key":"9916_CR33","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1158\/1078-0432.CCR-09-2564","volume":"16","author":"DJ Sanz","year":"2010","unstructured":"Sanz DJ, Acedo A, Infante M et al (2010) A high proportion of DNA variants of BRCA1 and BRCA2 is associated with aberrant splicing in breast\/ovarian cancer patients. Clin Cancer Res 16(6):1957\u20131967. doi: 10.1158\/1078-0432.CCR-09-2564","journal-title":"Clin Cancer Res"},{"issue":"6","key":"9916_CR34","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.molcel.2006.05.022","volume":"22","author":"B Xia","year":"2006","unstructured":"Xia B, Sheng Q, Nakanishi K et al (2006) Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. Mol Cell 22(6):719\u2013729. doi: 10.1016\/j.molcel.2006.05.022","journal-title":"Mol Cell"},{"issue":"3","key":"9916_CR35","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.jmoldx.2014.01.005","volume":"16","author":"C Santos","year":"2014","unstructured":"Santos C, Peixoto A, Rocha P et al (2014) Pathogenicity evaluation of BRCA1 and BRCA2 unclassified variants identified in Portuguese breast\/ovarian cancer families. J Mol Diagn 16(3):324\u2013334. doi: 10.1016\/j.jmoldx.2014.01.005","journal-title":"J Mol Diagn"},{"issue":"8","key":"9916_CR36","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1002\/humu.22101","volume":"33","author":"C Houdayer","year":"2012","unstructured":"Houdayer C, Caux-Moncoutier V, Krieger S et al (2012) Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico\/in vitro studies on BRCA1 and BRCA2 variants. Hum Mutat 33(8):1228\u20131238. doi: 10.1002\/humu.22101","journal-title":"Hum Mutat"},{"issue":"12","key":"9916_CR37","doi-asserted-by":"publisher","first-page":"4880","DOI":"10.1158\/0008-5472.CAN-09-4563","volume":"70","author":"MS Lee","year":"2010","unstructured":"Lee MS, Green R, Marsillac SM et al (2010) Comprehensive analysis of missense variations in the BRCT domain of BRCA1 by structural and functional assays. Cancer Res 70(12):4880\u20134890. doi: 10.1158\/0008-5472.CAN-09-4563","journal-title":"Cancer Res"},{"issue":"4","key":"9916_CR38","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1136\/jmedgenet-2014-102766","volume":"52","author":"A Jhuraney","year":"2015","unstructured":"Jhuraney A, Velkova A, Johnson RC et al (2015) BRCA1 Circos: a visualisation resource for functional analysis of missense variants. J Med Genet 52(4):224\u2013230. doi: 10.1136\/jmedgenet-2014-102766","journal-title":"J Med Genet"},{"key":"9916_CR39","doi-asserted-by":"publisher","unstructured":"Lek M, Karczewski K, Minikel E, et al (2015) Analysis of protein-coding genetic variation in 60,706 humans. Biorxiv. doi: 10.1101\/030338","DOI":"10.1101\/030338"},{"issue":"2","key":"9916_CR40","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1136\/jmg.2006.044388","volume":"44","author":"J Simard","year":"2007","unstructured":"Simard J, Dumont M, Moisan AM et al (2007) Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer. J Med Genet 44(2):107\u2013121. doi: 10.1136\/jmg.2006.044388","journal-title":"J Med Genet"},{"issue":"11","key":"9916_CR41","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/ejhg.2014.16","volume":"22","author":"L Castera","year":"2014","unstructured":"Castera L, Krieger S, Rousselin A et al (2014) Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes. Eur J Hum Genet 22(11):1305\u20131313. doi: 10.1038\/ejhg.2014.16","journal-title":"Eur J Hum Genet"},{"issue":"12","key":"9916_CR42","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1002\/humu.21608","volume":"32","author":"GA Millot","year":"2011","unstructured":"Millot GA, Berger A, Lejour V et al (2011) Assessment of human Nter and Cter BRCA1 mutations using growth and localization assays in yeast. Hum Mutat 32(12):1470\u20131480. doi: 10.1002\/humu.21608","journal-title":"Hum Mutat"},{"issue":"8","key":"9916_CR43","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1038\/sj.bjc.6600840","volume":"88","author":"Scottish\/Northern Irish BBC","year":"2003","unstructured":"Scottish\/Northern Irish BBC (2003) BRCA1 and BRCA2 mutations in Scotland and Northern Ireland. Br J Cancer 88(8):1256\u20131262. doi: 10.1038\/sj.bjc.6600840","journal-title":"Br J Cancer"},{"issue":"7","key":"9916_CR44","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1136\/jmg.2007.056895","volume":"45","author":"C Bonnet","year":"2008","unstructured":"Bonnet C, Krieger S, Vezain M et al (2008) Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene. J Med Genet 45(7):438\u2013446. doi: 10.1136\/jmg.2007.056895","journal-title":"J Med Genet"},{"issue":"15\u201316","key":"9916_CR45","first-page":"223","volume":"131","author":"F Schoumacher","year":"2001","unstructured":"Schoumacher F, Glaus A, Mueller H, Eppenberger U, Bolliger B, Senn HJ (2001) BRCA1\/2 mutations in Swiss patients with familial or early-onset breast and ovarian cancer. Swiss Med Wkly 131(15\u201316):223\u2013226","journal-title":"Swiss Med Wkly"},{"issue":"6","key":"9916_CR46","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/(SICI)1098-2272(1996)13:6<595::AID-GEPI5>3.0.CO;2-#","volume":"13","author":"DF Barker","year":"1996","unstructured":"Barker DF, Almeida ER, Casey G et al (1996) BRCA1 R841\u00a0W: a strong candidate for a common mutation with moderate phenotype. Genet Epidemiol 13(6):595\u2013604. doi:10.1002\/(SICI)1098-2272(1996)13:6<595:AID-GEPI5>3.0.CO;2-#","journal-title":"Genet Epidemiol"},{"issue":"6","key":"9916_CR47","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/hmg\/5.6.835","volume":"5","author":"F Durocher","year":"1996","unstructured":"Durocher F, Shattuck-Eidens D, McClure M et al (1996) Comparison of BRCA1 polymorphisms, rare sequence variants and\/or missense mutations in unaffected and breast\/ovarian cancer populations. Hum Mol Genet 5(6):835\u2013842","journal-title":"Hum Mol Genet"},{"issue":"4","key":"9916_CR48","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1086\/424388","volume":"75","author":"DE Goldgar","year":"2004","unstructured":"Goldgar DE, Easton DF, Deffenbaugh AM et al (2004) Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2. Am J Hum Genet 75(4):535\u2013544. doi: 10.1086\/424388","journal-title":"Am J Hum Genet"},{"issue":"1\u20132","key":"9916_CR49","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s004399900085","volume":"105","author":"RC Panguluri","year":"1999","unstructured":"Panguluri RC, Brody LC, Modali R et al (1999) BRCA1 mutations in African Americans. Hum Genet 105(1\u20132):28\u201331","journal-title":"Hum Genet"},{"issue":"10","key":"9916_CR50","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/jmg.36.10.747","volume":"36","author":"NJ Orsouw van","year":"1999","unstructured":"van Orsouw NJ, Dhanda RK, Elhaji Y et al (1999) A highly accurate, low cost test for BRCA1 mutations. J Med Genet 36(10):747\u2013753","journal-title":"J Med Genet"},{"issue":"4","key":"9916_CR51","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/hmg\/10.4.353","volume":"10","author":"J Vallon-Christersson","year":"2001","unstructured":"Vallon-Christersson J, Cayanan C, Haraldsson K et al (2001) Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families. Hum Mol Genet 10(4):353\u2013360","journal-title":"Hum Mol Genet"},{"issue":"5\u20136","key":"9916_CR52","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1007\/s00439-003-0908-6","volume":"112","author":"CL Scott","year":"2003","unstructured":"Scott CL, Jenkins MA, Southey MC et al (2003) Average age-specific cumulative risk of breast cancer according to type and site of germline mutations in BRCA1 and BRCA2 estimated from multiple-case breast cancer families attending Australian family cancer clinics. Hum Genet 112(5\u20136):542\u2013551. doi: 10.1007\/s00439-003-0908-6","journal-title":"Hum Genet"},{"issue":"1","key":"9916_CR53","doi-asserted-by":"publisher","first-page":"60","DOI":"10.7150\/ijms.5014","volume":"10","author":"A Laraqui","year":"2013","unstructured":"Laraqui A, Uhrhammer N, Lahlou-Amine I et al (2013) Mutation screening of the BRCA1 gene in early onset and familial breast\/ovarian cancer in Moroccan population. Int J Med Sci 10(1):60\u201367. doi: 10.7150\/ijms.5014","journal-title":"Int J Med Sci"},{"issue":"4","key":"9916_CR54","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1158\/0008-5472.CAN-05-3546","volume":"66","author":"G Chenevix-Trench","year":"2006","unstructured":"Chenevix-Trench G, Healey S, Lakhani S et al (2006) Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance. Cancer Res 66(4):2019\u20132027. doi: 10.1158\/0008-5472.CAN-05-3546","journal-title":"Cancer Res"},{"issue":"5","key":"9916_CR55","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/humu.9188","volume":"22","author":"JI Martinez-Ferrandis","year":"2003","unstructured":"Martinez-Ferrandis JI, Vega A, Chirivella I et al (2003) Mutational analysis of BRCA1 and BRCA2 in Mediterranean Spanish women with early-onset breast cancer: identification of three novel pathogenic mutations. Hum Mutat 22(5):417\u2013418. doi: 10.1002\/humu.9188","journal-title":"Hum Mutat"},{"issue":"18","key":"9916_CR56","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/jnci\/94.18.1396","volume":"94","author":"JL Hilton","year":"2002","unstructured":"Hilton JL, Geisler JP, Rathe JA, Hattermann-Zogg MA, DeYoung B, Buller RE (2002) Inactivation of BRCA1 and BRCA2 in ovarian cancer. J Natl Cancer Inst 94(18):1396\u20131406","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"9916_CR57","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1038\/ejhg.2011.100","volume":"19","author":"JC Thery","year":"2011","unstructured":"Thery JC, Krieger S, Gaildrat P et al (2011) Contribution of bioinformatics predictions and functional splicing assays to the interpretation of unclassified variants of the BRCA genes. Eur J Hum Genet 19(10):1052\u20131058. doi: 10.1038\/ejhg.2011.100","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"9916_CR58","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/humu.22478","volume":"35","author":"L Guidugli","year":"2014","unstructured":"Guidugli L, Carreira A, Caputo SM et al (2014) Functional assays for analysis of variants of uncertain significance in BRCA2. Hum Mutat 35(2):151\u2013164. doi: 10.1002\/humu.22478","journal-title":"Hum Mutat"},{"key":"9916_CR59","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2350-12-9","volume":"12","author":"V Stegel","year":"2011","unstructured":"Stegel V, Krajc M, Zgajnar J et al (2011) The occurrence of germline BRCA1 and BRCA2 sequence alterations in Slovenian population. BMC Med Genet 12:9. doi: 10.1186\/1471-2350-12-9","journal-title":"BMC Med Genet"},{"issue":"3","key":"9916_CR60","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/hmg\/8.3.413","volume":"8","author":"TM Wagner","year":"1999","unstructured":"Wagner TM, Hirtenlehner K, Shen P et al (1999) Global sequence diversity of BRCA2: analysis of 71 breast cancer families and 95 control individuals of worldwide populations. Hum Mol Genet 8(3):413\u2013423","journal-title":"Hum Mol Genet"},{"key":"9916_CR61","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.1038\/ncomms4156","volume":"5","author":"KL Kanchi","year":"2014","unstructured":"Kanchi KL, Johnson KJ, Lu C et al (2014) Integrated analysis of germline and somatic variants in ovarian cancer. Nat Commun 5:3156. doi: 10.1038\/ncomms4156","journal-title":"Nat Commun"},{"key":"9916_CR62","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4137\/CIN.S618","volume":"6","author":"R Karchin","year":"2008","unstructured":"Karchin R, Agarwal M, Sali A, Couch F, Beattie MS (2008) Classifying Variants of Undetermined Significance in BRCA2 with protein likelihood ratios. Cancer Inform 6:203\u2013216","journal-title":"Cancer Inform"},{"issue":"1","key":"9916_CR63","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1158\/0008-5472.CAN-12-2081","volume":"73","author":"L Guidugli","year":"2013","unstructured":"Guidugli L, Pankratz VS, Singh N et al (2013) A classification model for BRCA2 DNA binding domain missense variants based on homology-directed repair activity. Cancer Res 73(1):265\u2013275. doi: 10.1158\/0008-5472.CAN-12-2081","journal-title":"Cancer Res"},{"issue":"3","key":"9916_CR64","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/humu.9014","volume":"19","author":"G Llort","year":"2002","unstructured":"Llort G, Munoz CY, Tuser MP et al (2002) Low frequency of recurrent BRCA1 and BRCA2 mutations in Spain. Hum Mutat 19(3):307. doi: 10.1002\/humu.9014","journal-title":"Hum Mutat"},{"issue":"3","key":"9916_CR65","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s10549-011-1661-5","volume":"132","author":"M Menendez","year":"2012","unstructured":"Menendez M, Castellsague J, Mirete M et al (2012) Assessing the RNA effect of 26 DNA variants in the BRCA1 and BRCA2 genes. Breast Cancer Res Treat 132(3):979\u2013992. doi: 10.1007\/s10549-011-1661-5","journal-title":"Breast Cancer Res Treat"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-016-9916-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10689-016-9916-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-016-9916-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-016-9916-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T03:14:46Z","timestamp":1568258086000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-016-9916-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,5]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["9916"],"URL":"https:\/\/doi.org\/10.1007\/s10689-016-9916-2","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"type":"print","value":"1389-9600"},{"type":"electronic","value":"1573-7292"}],"subject":[],"published":{"date-parts":[[2016,8,5]]}}}